OriGene Logo

Customer Login

Checkout as a new customer

Creating an account has many benefits:

  • See order and shipping status
  • Track order history
  • Check out faster
Create an Account

TissueScan, Ovarian Cancer cDNA Array III

Be the first to review this product
SKU
HORT103
48 samples covering 6-normal, 9-Stage IA, 2-IB, 3-IC, 3-IIB, 1-IIC, 1-II, 3-IIIA, 6-IIIB, 12-IIIC, 1-III, 1-IV. Available in 2, 5, 10 identical plates.
  $1,060.00
In Stock*

Frequently Bought Together (4)

D11-18 Polink-1 HRP Polymer Detection for MOUSE and RABBIT antibodies on human tissue
18 ml
$420.00
D12-6 Polink-1 HRP Polymer Detection for MOUSE antibody on human or animal tissue (non-rodent)
6 ml
$250.00
HP205798 qSTAR qPCR primer pairs against Homo sapiens gene GAPDH 200 reactions
$150.00
MP205604 qSTAR qPCR primer pairs against Mus musculus gene Gapdh 200 reactions
$150.00
Specifications
Specifications
Product Data
TissueScan Type Cancer Specific
Array Name Ovarian Cancer cDNA Array III
Clinical Info
Diagnosis Category Ovarian Cancer
Tissue Ovary
Shipping Ambient
Description 48 samples covering 6-normal, 9-Stage IA, 2-IB, 3-IC, 3-IIB, 1-IIC, 1-II, 3-IIIA, 6-IIIB, 12-IIIC, 1-III, 1-IV. Available in 2, 5, 10 identical plates.
Reviews
Write Review
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

Role of alternatively spliced, pro-survival Protein Kinase C delta VIII (PKCδVIII) in ovarian cancer
Patel, Rupani, Impreso et al
FASEB Bioadv (2022) 4 (4), 235-253 DOI: 10.1096/fba.2021-00090
Cited by 6
AI Summary: In this study, OriGene products—specifically, PKCδVIII cDNA (RC222327) and PKCδVIII shRNA (TL313755)—were used for overexpression and knockdown experiments to investigate the role of PKCδVIII in promoting survival and migration of ovarian cancer cells.
FigureFigureFigure
Inhibition of Transient Receptor Potential Vanilloid 6 channel, elevated in human ovarian cancers, reduces tumour growth in a xenograft model
Xue, Wang, MacCormack et al
J Cancer (2018) 9 (17), 3196-3207 DOI: 10.7150/jca.20639
Cited by 53
AI Summary: OriGene products, specifically the TRPV6 antibody (Cat# TA326183) and TRPV6 qPCR primer set (Cat# HP208799), were used in this study to detect and quantify TRPV6 mRNA and protein levels in ovarian cancer tissues and cell lines, enabling the researchers to demonstrate elevated TRPV6 expression and assess the effects of TRPV6 inhibition on tumor growth.
FigureFigureFigure
Elevated NIBP/TRAPPC9 mediates tumorigenesis of cancer cells through NFκB signaling
Zhang, Liu, Wang et al
Oncotarget (2015) 6 (8), 6160-78 DOI: 10.18632/oncotarget.3349
Cited by 28
AI Summary: OriGene’s Human Cancer Survey TissueScan cDNA Array (OriGene, CSRT101) was used to analyze NIBP expression levels across various tumor tissues, contributing key data to demonstrate NIBP’s extensive expression in breast and colon cancers in this study.
FigureFigureFigure
Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes
Tamir, Jag, Sarojini et al
J Ovarian Res (2014) 7 (1), 109 DOI: 10.1186/PREACCEPT-1736656869122663
AI Summary: OriGene’s TissueScan Cancer Survey Panel and OVC Panel I-IV were used for expression screening and validation of KLK6 and KLK7 biomarkers in various cancer types and ovarian cancer subtypes, supporting the identification of these genes as potential early detection markers for ovarian cancer.
Snippet: Poor quality specimens that produced no meaningful values after 40 cycles of qPCR were not included in the data processing steps. The TissueScan Cancer Survey Panel and OVC Panel I-IV (both from OriGene, Rockville, MD) were used as described by the manufacturer ... Cite SaveSaving
Doxorubicin synergizes with 34.5ENVE to enhance antitumor efficacy against metastatic ovarian cancer
Bolyard, Yoo, Wang et al
Clin. Cancer Res. (2014)
AI Summary: OriGene’s TissueScan qPCR Array Ovarian Cancer Disease Panel III was used in this study to assess nestin expression in 48 human ovarian cancer samples, contributing to the evaluation of the oncolytic virus’s target specificity.
Snippet: CACACTGTGCCCATCTATGAGG-3';reverse, 5'- CGCGCTCAGTGAGGATCTTC- 3'. TissueScan qPCR Array Ovarian Cancer Disease Panel III (Origene, Rockville MD) was used to ... (Origene, Rockville MD) was used to assess nestin expression in 48 human samples ... Cite SaveSaving
BET Bromodomain Inhibition as a Therapeutic Strategy in Ovarian Cancer by Downregulating FoxM1
Zhang, Ma, Jing et al
Theranostics (2015) 6 (2), 219-230
AI Summary: OriGene’s TissueScan cDNA arrays were used in this study to analyze gene expression profiles in ovarian cancer samples, contributing to the investigation of BET bromodomain inhibition as a therapeutic strategy.
Snippet: At least three biological replicates were included for each condition. TissueScan cDNA arrays were purchased from OriGene Technologies. Chromatin precipitation Chromatin precipitation was performed as pre- viously described [30]. ... Cite SaveSaving
Showing 1-6 of 6 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products